These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25596080)

  • 1. Aberrant promoter hypermethylation of p16 gene in endometrial carcinoma.
    Hu ZY; Tang LD; Zhou Q; Xiao L; Cao Y
    Tumour Biol; 2015 Mar; 36(3):1487-91. PubMed ID: 25596080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma.
    Su L; Wang H; Miao J; Liang Y
    Sci Rep; 2015 Aug; 5():13238. PubMed ID: 26283007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation in the p16 promoter region in the carcinogenesis of endometrial cancer in Japanese patients.
    Yanokura M; Banno K; Susumu N; Kawaguchi M; Kuwabara Y; Tsukazaki K; Aoki D
    Anticancer Res; 2006; 26(2A):851-6. PubMed ID: 16619479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant DNA hypermethylation of hMLH-1 and CDKN2A/p16 genes in benign, premalignant and malignant endometrial lesions.
    Guida M; Sanguedolce F; Bufo P; Di Spiezio Sardo A; Bifulco G; Nappi C; Pannone G
    Eur J Gynaecol Oncol; 2009; 30(3):267-70. PubMed ID: 19697618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Methylation and expression of the p16 gene in endometrial carcinoma].
    Chao H; Sun J; Lu S
    Zhonghua Zhong Liu Za Zhi; 2000 May; 22(3):228-31. PubMed ID: 11778238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16INK4A alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas.
    Semczuk A; Boltze C; Marzec B; Szczygielska A; Roessner A; Schneider-Stock R
    J Cancer Res Clin Oncol; 2003 Oct; 129(10):589-96. PubMed ID: 12920579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of inactivation of the p16INK4a gene in leiomyosarcoma of soft tissue: decreased p16 expression correlates with promoter methylation and poor prognosis.
    Kawaguchi K; Oda Y; Saito T; Yamamoto H; Tamiya S; Takahira T; Miyajima K; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2003 Nov; 201(3):487-95. PubMed ID: 14595762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16 alterations increase the metastatic potential of endometrial carcinoma.
    Ignatov A; Bischoff J; Schwarzenau C; Krebs T; Kuester D; Herrmann K; Costa SD; Roessner A; Semczuk A; Schneider-Stock R
    Gynecol Oncol; 2008 Nov; 111(2):365-71. PubMed ID: 18790522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis.
    Salvesen HB; Das S; Akslen LA
    Clin Cancer Res; 2000 Jan; 6(1):153-9. PubMed ID: 10656444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 promoter hypermethylation is associated with increased breast cancer risk.
    Wang L; Tang L; Xie R; Nie W; Chen L; Guan X
    Mol Med Rep; 2012 Oct; 6(4):904-8. PubMed ID: 22824969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
    Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
    Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of p16-cyclin d/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma.
    Tsuda H; Yamamoto K; Inoue T; Uchiyama I; Umesaki N
    Br J Cancer; 2000 Feb; 82(3):675-82. PubMed ID: 10682682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between p16 gene promoter methylation and clinicopathologic features of colorectal cancer: a meta-analysis of 27 cohort studies.
    Chen YZ; Liu D; Zhao YX; Wang HT; Gao Y; Chen Y
    DNA Cell Biol; 2014 Oct; 33(10):729-38. PubMed ID: 24979649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of p16 and p15 genes in human uterine tumours.
    Nakashima R; Fujita M; Enomoto T; Haba T; Yoshino K; Wada H; Kurachi H; Sasaki M; Wakasa K; Inoue M; Buzard G; Murata Y
    Br J Cancer; 1999 May; 80(3-4):458-67. PubMed ID: 10408854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa.
    Kato K; Hara A; Kuno T; Mori H; Yamashita T; Toida M; Shibata T
    J Cancer Res Clin Oncol; 2006 Nov; 132(11):735-43. PubMed ID: 16791592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p16INK4a gene promoter hypermethylation in mucosa as a prognostic factor for patients with colorectal cancer.
    Wettergren Y; Odin E; Nilsson S; Carlsson G; Gustavsson B
    Mol Med; 2008; 14(7-8):412-21. PubMed ID: 18418463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of the p16 gene promoter in pterygia and its association with the expression of DNA methyltransferase 3b.
    Chen PL; Cheng YW; Chiang CC; Tseng SH; Chau PS; Tsai YY
    Mol Vis; 2006 Nov; 12():1411-6. PubMed ID: 17149367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
    Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
    Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene BMI-1 in squamous cell lung carcinoma and premalignant endobronchial lesions.
    Breuer RH; Snijders PJ; Sutedja GT; Sewalt RG; Otte AP; Postmus PE; Meijer CJ; Raaphorst FM; Smit EF
    Lung Cancer; 2005 Jun; 48(3):299-306. PubMed ID: 15892997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma.
    He M; Aisner S; Benevenia J; Patterson F; Harrison LE; Hameed M
    Pathol Res Pract; 2009; 205(6):386-94. PubMed ID: 19186005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.